β-arrestin interactions to non-receptor proteins Identification of Gα12-vs-Gα13-coupling determinants and development

All the above lightly represent the potential applications of Nbs to facilitate the development of more

in a range of diseases, and understanding the mechanisms of these complex molecules is crucial for developing

Quarter 2024 Crinetics Pharmaceuticals To Present Advancements From Atumelnant (Crn04894) And Paltusotine Development

of chemokine binding and receptor activation will pave the way for significant advancements in the development

discoveries of important principles for drug treatment.[24–30] Black was particularly interested in developing